Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04385394 · ClinicalTrials.gov registry record
Bright Light Therapy as Augmentation of Depressive Symptoms on Acute Psychiatric Floor
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- 100
- Enrollment target
NCT04385394: Completed study, sponsored by State University of New York - Upstate Medical University.
NCT04385394 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04385394 has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to explore if Bright Light Therapy (BLT) as augmentation of depression treatment on an acute psychiatric floor is feasible, helps alleviate depressive symptoms, improve functioning, and decrease length of stay on the psychiatric floor.
Primary Outcome
changes in depression scores, administered before light therapy and prior to discharge (corresponds to the last session of light therapy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-01-30 |
| Est. Completion | 2020-08-20 |
What the finished NCT04385394 record still lists
NCT04385394 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04385394 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04385394 about?
NCT04385394 is a clinical study titled "Bright Light Therapy as Augmentation of Depressive Symptoms on Acute Psychiatric Floor". The purpose of this study is to explore if Bright Light Therapy (BLT) as augmentation of depression treatment on an acute psychiatric floor is feasible, helps alleviate depressive symptoms, improve functioning, and decrease length of stay on the psychiatric floor.
What is the current status of trial NCT04385394?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2020-01-30. Estimated completion is 2020-08-20.
Who is sponsoring clinical trial NCT04385394?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI